Literature DB >> 23659831

Fracture history of healthy premenopausal women is associated with a reduction of cortical microstructural components at the distal radius.

T Chevalley1, J P Bonjour, B van Rietbergen, S Ferrari, R Rizzoli.   

Abstract

OBJECTIVES: The objective of this study is to determine in healthy premenopausal women with a history of fracture which bone structural components of the distal radius are the most closely associated with a risk of fracture. METHODS AND PARTICIPANTS: The method was as follows: measurement of radial areal bone mineral density (aBMD) by DXA, microstructural components by high-resolution quantitative peripheral computerized tomography (HR-pQCT) and strength variables by micro Finite Element Analysis (μFEA) in 196 healthy premenopausal women aged 45.9 ± 3.7 (± SD) years with (FX, n = 96) and without (NO-FX, n = 100) a history of fracture. We evaluated differences in T-scores between FX and NO-FX and risk of fracture by Odds ratios (OR with 95% confidence intervals, CI) per one SD decrease, using logistic regression analysis after adjustment for age, height, weight, menarcheal age, calcium and protein intakes, and physical activity.
RESULTS: In the whole group the mean radial metaphysis aBMD T-score was not significantly different from zero. In the FX as compared to the NO-FX group, the differences in T-scores were as follows: for radial metaphysis: aBMD, -0.24 (P = 0.005); for distal radius microstructure components: cortical volumetric BMD, -0.38 (P = 0.0009); cortical thickness, -0.37 (P = 0.0001); cross-sectional area (CSA), +0.24 (P=0.034); and endosteal perimeter, +0.28 (P = 0.032); and for strength estimates: stiffness, -0.15 (P = 0.030); failure load, -0.14 (P = 0.044); and apparent modulus, -0.28 (P = 0.006). T-scores of trabecular volumetric BMD and thickness did not significantly differ between the FX and the NO-FX group. Accordingly, the risk of fracture (OR, 95% CI) for 1 SD decrease in radius bone parameters was as follows: radial metaphysis aBMD: 1.70 (1.18-2.44), P = 0.004; cortical volumetric BMD: 1.86 (1.28-2.71), P = 0.001; and cortical thickness: 2.36 (1.53-3.63), P = 0.0001. The corresponding fracture risk for the strength estimates was as follows: stiffness: 1.66 (1.06-2.61), P = 0.028; failure load: 1.59 (1.02-2.47), P = 0.041; and apparent modulus: 1.76 (1.17-2.64), P = 0.006.
CONCLUSIONS: In healthy premenopausal women, a history of fracture is associated with reduced T-scores in the distal radius, with the cortical components showing the greatest deficit. A reduction of one SD in cortical thickness is associated with a nearly three-fold increased risk of fracture. This finding strengthens the notion that, in healthy women, a certain degree of bone structural fragility contributes to fractures before the menopause and therefore should be taken into consideration in the individual prevention strategy of postmenopausal osteoporosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23659831     DOI: 10.1016/j.bone.2013.04.025

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  14 in total

Review 1.  Clinical Evaluation of Bone Strength and Fracture Risk.

Authors:  Chantal M J de Bakker; Wei-Ju Tseng; Yihan Li; Hongbo Zhao; X Sherry Liu
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

2.  Artificially low cortical bone mineral density in Turner syndrome is due to the partial volume effect.

Authors:  O Soucek; E Schönau; J Lebl; Z Sumnik
Journal:  Osteoporos Int       Date:  2014-10-07       Impact factor: 4.507

3.  Diminished bone strength is observed in adult women and men who sustained a mild trauma distal forearm fracture during childhood.

Authors:  Joshua N Farr; Sundeep Khosla; Sara J Achenbach; Elizabeth J Atkinson; Salman Kirmani; Louise K McCready; L Joseph Melton; Shreyasee Amin
Journal:  J Bone Miner Res       Date:  2014-10       Impact factor: 6.741

4.  Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations.

Authors:  E Biver; C Durosier; T Chevalley; F R Herrmann; S Ferrari; R Rizzoli
Journal:  Osteoporos Int       Date:  2015-04-08       Impact factor: 4.507

Review 5.  A Comparison of Peripheral Imaging Technologies for Bone and Muscle Quantification: a Mixed Methods Clinical Review.

Authors:  Andy Kin On Wong
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

6.  The comparability of HR-pQCT bone measurements is improved by scanning anatomically standardized regions.

Authors:  S Bonaretti; S Majumdar; T F Lang; S Khosla; A J Burghardt
Journal:  Osteoporos Int       Date:  2017-04-08       Impact factor: 4.507

7.  Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal women.

Authors:  E Biver; C Durosier-Izart; F Merminod; T Chevalley; B van Rietbergen; S L Ferrari; R Rizzoli
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

Review 8.  Tissue-Level Mechanical Properties of Bone Contributing to Fracture Risk.

Authors:  Jeffry S Nyman; Mathilde Granke; Robert C Singleton; George M Pharr
Journal:  Curr Osteoporos Rep       Date:  2016-08       Impact factor: 5.096

9.  High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients.

Authors:  Judith Haschka; Simon Hirschmann; Arnd Kleyer; Matthias Englbrecht; Francesca Faustini; David Simon; Camille P Figueiredo; Louis Schuster; Christian Muschitz; Roland Kocijan; Heinrich Resch; Raja Atreya; Jürgen Rech; Markus F Neurath; Georg Schett
Journal:  J Crohns Colitis       Date:  2016-01-27       Impact factor: 9.071

10.  Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and women.

Authors:  E Biver; J Pepe; A de Sire; T Chevalley; S Ferrari
Journal:  Osteoporos Int       Date:  2018-10-10       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.